Skip to main content

Foghorn Therapeutics Inc.

FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822462

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Foghorn Therapeutics Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of FHTX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders6972+3
Shares26.5M39.4M+13.0M (+49.1%)
Value$177.4M$226.9M+$49.4M (+27.8%)

New holders (16)

Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to FHTX in Q2 2024
InstitutionSharesValue% of portfolio
BVF Inc5,302,000$30.5M0.85%
Deerfield Management Company, L.P. (Series C)2,518,500$14.5M0.24%
Perceptive Advisors LLC544,000$3.13M0.08%
Bridgeway Capital Management, LLC57,500$330.6K0.01%
Wellington Management Group LLP43,789$251.8K0.00%
DAFNA Capital Management LLC41,850$240.6K0.06%
Jane Street Group, LLC34,127$196.2K0.00%
D. E. Shaw & Co., Inc.25,738$148.0K0.00%
Corton Capital Inc.24,207$139.2K0.07%
Walleye Capital LLC17,145$98.6K0.00%
Corebridge Financial, Inc.13,587$78.1K0.00%
Manufacturers Life Insurance Company, The11,200$64.4K0.00%
Renaissance Technologies LLC10,700$61.5K0.00%
Mirae Asset Global ETFs Holdings Ltd.9,762$56.1K0.00%
MetLife Investment Management6,940$39.9K0.00%
The PNC Financial Services Group, Inc.32$1840.00%

Sold out (13)

Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.